Financial Ratios Cell Impact AB Nasdaq Stockholm
Stocks
CI BTU
SE0029605500
Industrial Machinery & Equipment
|
Market Closed -
Nasdaq Stockholm
19:00:00 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.2755 SEK | -4.34% |
|
+0.18% | - |
| 09-01 | 17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 08-28 | 11 stocks have so far today posted new 52-week lows on the Stockholm Stock Exchange | FW |
| Fiscal Period: December | 2016 (SEK) | 2017 (SEK) | 2018 (SEK) | 2019 (SEK) | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) | 2025 (SEK) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -20.26 | -20.32 | -19.06 | -19.24 | -37.66 | |||||
Return on Total Capital | -25.27 | -24.49 | -20.88 | -20.76 | -40.21 | |||||
Return On Equity % | -46.36 | -44.63 | -38.68 | -38.45 | -77.61 | |||||
Return on Common Equity | -46.36 | -44.63 | -38.68 | -38.45 | -77.61 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.64 | 40.36 | 54.24 | 15.86 | -87.41 | |||||
SG&A Margin | 125.52 | 135.48 | 251.86 | 164.2 | 825.85 | |||||
EBITDA Margin % | -88.38 | -101.49 | -226.77 | -211.37 | -1.86K | |||||
EBITA Margin % | -95.26 | -113.3 | -249.79 | -260.19 | -2.24K | |||||
EBIT Margin % | -95.4 | -113.71 | -250.7 | -261.11 | -2.25K | |||||
Income From Continuing Operations Margin % | -97.62 | -113.86 | -254.71 | -264.83 | -2.32K | |||||
Net Income Margin % | -97.62 | -113.86 | -254.71 | -264.83 | -2.32K | |||||
Net Avail. For Common Margin % | -97.62 | -113.86 | -254.71 | -264.83 | -2.32K | |||||
Normalized Net Income Margin | -60.92 | -71.12 | -159.15 | -165.38 | -1.45K | |||||
Levered Free Cash Flow Margin | -134.69 | -148.73 | -222.81 | -147.57 | -1.02K | |||||
Unlevered Free Cash Flow Margin | -133.4 | -147.68 | -218.81 | -143.34 | -971.2 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.34 | 0.29 | 0.12 | 0.12 | 0.03 | |||||
Fixed Assets Turnover | 0.99 | 0.7 | 0.27 | 0.2 | 0.04 | |||||
Receivables Turnover (Average Receivables) | 4.09 | 3.79 | 5.56 | 61.69 | 8.24 | |||||
Inventory Turnover (Average Inventory) | 3.1 | 1.59 | 0.39 | 0.61 | 0.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.6 | 5.43 | 3.58 | 3.03 | 2.02 | |||||
Quick Ratio | 0.75 | 4.33 | 2.23 | 1.07 | 0.58 | |||||
Operating Cash Flow to Current Liabilities | -1.08 | -2.42 | -2.1 | -2.58 | -1.28 | |||||
Days Sales Outstanding (Average Receivables) | 89.35 | 96.3 | 65.61 | 5.93 | 44.3 | |||||
Days Outstanding Inventory (Average Inventory) | 117.75 | 229.7 | 926.14 | 602.09 | 1.56K | |||||
Average Days Payable Outstanding | 74.47 | 65.33 | 106.09 | 218.29 | 55.53 | |||||
Cash Conversion Cycle (Average Days) | 132.64 | 260.68 | 885.67 | 389.74 | 1.55K | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 13.68 | 13.78 | 14.09 | 14.11 | 22.01 | |||||
Total Debt / Total Capital | 12.03 | 12.11 | 12.35 | 12.37 | 18.04 | |||||
LT Debt/Equity | 11.27 | 10.28 | 10.01 | 8.26 | 5.76 | |||||
Long-Term Debt / Total Capital | 9.91 | 9.03 | 8.78 | 7.24 | 4.72 | |||||
Total Liabilities / Total Assets | 40.26 | 19.22 | 20.57 | 16.14 | 25.92 | |||||
EBIT / Interest Expense | -46.18 | -67.67 | -39.13 | -38.62 | -28.99 | |||||
EBITDA / Interest Expense | -40.73 | -58.05 | -34.08 | -29.57 | -22.95 | |||||
(EBITDA - Capex) / Interest Expense | -72.08 | -98.64 | -50.05 | -34.4 | -23.39 | |||||
Total Debt / EBITDA | -0.28 | -0.5 | -0.41 | -0.41 | -0.26 | |||||
Net Debt / EBITDA | 0.13 | 1.34 | 0.55 | -0.14 | -0.16 | |||||
Total Debt / (EBITDA - Capex) | -0.16 | -0.29 | -0.28 | -0.35 | -0.26 | |||||
Net Debt / (EBITDA - Capex) | 0.07 | 0.79 | 0.37 | -0.12 | -0.15 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 179.1 | 11.89 | -38.67 | -20.43 | -85.01 | |||||
Gross Profit, 1 Yr. Growth % | 82.26 | 5.92 | -31.67 | -76.74 | -182.65 | |||||
EBITDA, 1 Yr. Growth % | 85.71 | 28.49 | 17.12 | -24.61 | 31.73 | |||||
EBITA, 1 Yr. Growth % | 81.26 | 33.08 | 15.49 | -17.12 | 29.21 | |||||
EBIT, 1 Yr. Growth % | 81.25 | 33.36 | 15.49 | -17.13 | 29.18 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 80.43 | 30.51 | 16.49 | -17.27 | 31.41 | |||||
Net Income, 1 Yr. Growth % | 80.43 | 30.51 | 16.49 | -17.27 | 31.41 | |||||
Normalized Net Income, 1 Yr. Growth % | 80.15 | 30.62 | 16.53 | -17.32 | 31.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 53.35 | 2.05 | -19.54 | -85.33 | -51.95 | |||||
Accounts Receivable, 1 Yr. Growth % | 122.86 | -31.89 | -96.52 | 11.91 | 11.58 | |||||
Inventory, 1 Yr. Growth % | 162.54 | 113.37 | 36.57 | -35.68 | 21.72 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 74.84 | 46.14 | 29.18 | -9.81 | -53.9 | |||||
Total Assets, 1 Yr. Growth % | -1.71 | 68.19 | -4.88 | -31.6 | -37.46 | |||||
Tangible Book Value, 1 Yr. Growth % | -29.66 | 127.71 | -6.41 | -28 | -44.82 | |||||
Common Equity, 1 Yr. Growth % | -29.35 | 127.41 | -6.47 | -27.78 | -44.76 | |||||
Cash From Operations, 1 Yr. Growth % | 80.85 | 23.07 | -4.68 | -41.19 | -27.11 | |||||
Capital Expenditures, 1 Yr. Growth % | 140.32 | 17.87 | -21.86 | -75.42 | -84.47 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 107.28 | 23.55 | -21.77 | -47.26 | 3.6 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 108.3 | 23.87 | -22.63 | -47.83 | 1.59 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 161.49 | 76.72 | -23.67 | -30.14 | -65.46 | |||||
Gross Profit, 2 Yr. CAGR % | 231.17 | 38.94 | -13.9 | -60.13 | -56.16 | |||||
EBITDA, 2 Yr. CAGR % | 27.61 | 54.47 | 22.27 | -6.8 | -0.34 | |||||
EBITA, 2 Yr. CAGR % | 28.2 | 55.32 | 23.61 | -2.17 | 3.48 | |||||
EBIT, 2 Yr. CAGR % | 28.2 | 55.47 | 23.74 | -2.17 | 3.47 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 28.45 | 53.45 | 23.3 | -1.83 | 4.27 | |||||
Net Income, 2 Yr. CAGR % | 28.45 | 53.45 | 23.3 | -1.83 | 4.27 | |||||
Normalized Net Income, 2 Yr. CAGR % | 28.35 | 53.4 | 23.38 | -1.84 | 4.28 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -3.44 | 25.09 | -9.39 | -65.64 | -73.45 | |||||
Accounts Receivable, 2 Yr. CAGR % | 231.35 | 23.2 | -84.61 | -80.27 | 11.74 | |||||
Inventory, 2 Yr. CAGR % | 224.12 | 136.68 | 70.7 | -6.27 | -11.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 97.7 | 59.85 | 37.4 | 7.94 | -35.52 | |||||
Total Assets, 2 Yr. CAGR % | 102.81 | 28.58 | 26.49 | -19.34 | -34.6 | |||||
Tangible Book Value, 2 Yr. CAGR % | 77.79 | 26.56 | 45.99 | -17.91 | -36.97 | |||||
Common Equity, 2 Yr. CAGR % | 77.92 | 26.75 | 45.84 | -17.81 | -36.84 | |||||
Cash From Operations, 2 Yr. CAGR % | 44.88 | 49.19 | 8.31 | -23.35 | -34.53 | |||||
Capital Expenditures, 2 Yr. CAGR % | 105.61 | 68.31 | -4.03 | -55.43 | -80.46 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 77.34 | 60.03 | -1.82 | -35.79 | -26.08 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 78.01 | 60.63 | -2.24 | -36.49 | -27.2 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 131.59 | 97.05 | 17.6 | -22.6 | -58.17 | |||||
Gross Profit, 3 Yr. CAGR % | 71.24 | 126.48 | 10.55 | -44.34 | -49.17 | |||||
EBITDA, 3 Yr. CAGR % | 19.92 | 27.9 | 40.55 | 3.5 | 4.59 | |||||
EBITA, 3 Yr. CAGR % | 20.47 | 29.8 | 40.43 | 8.19 | 7.34 | |||||
EBIT, 3 Yr. CAGR % | 20.47 | 29.9 | 40.53 | 8.26 | 7.33 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 21.45 | 29.13 | 39.98 | 7.94 | 8.19 | |||||
Net Income, 3 Yr. CAGR % | 21.45 | 29.13 | 39.98 | 7.94 | 8.19 | |||||
Normalized Net Income, 3 Yr. CAGR % | 21.39 | 29.1 | 39.97 | 7.97 | 8.22 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -20.1 | -1.65 | 7.98 | -50.61 | -61.58 | |||||
Accounts Receivable, 3 Yr. CAGR % | 109.8 | 95.55 | -62.49 | -70.19 | -64.85 | |||||
Inventory, 3 Yr. CAGR % | 166.3 | 181.96 | 97.04 | 23.3 | 2.26 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 83.43 | 78.76 | 48.89 | 19.41 | -18.72 | |||||
Total Assets, 3 Yr. CAGR % | 84.39 | 90.55 | 16.29 | 3.05 | -25.9 | |||||
Tangible Book Value, 3 Yr. CAGR % | 95.75 | 93.08 | 14.45 | 15.34 | -28.09 | |||||
Common Equity, 3 Yr. CAGR % | 95.33 | 93.09 | 14.54 | 15.38 | -28.01 | |||||
Cash From Operations, 3 Yr. CAGR % | 26.45 | 37.21 | 28.49 | -10.25 | -24.62 | |||||
Capital Expenditures, 3 Yr. CAGR % | 82.96 | 70.8 | 30.32 | -38.36 | -68.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 47.01 | 57.21 | 25.95 | -20.21 | -24.69 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 46.69 | 57.74 | 25.8 | -20.73 | -25.73 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 113.93 | 126.47 | 48.56 | 25.95 | -27.96 | |||||
Gross Profit, 5 Yr. CAGR % | 120.7 | 131.91 | 30.06 | 13.59 | -23.63 | |||||
EBITDA, 5 Yr. CAGR % | 55.6 | 40.28 | 20.85 | 12.54 | 22.09 | |||||
EBITA, 5 Yr. CAGR % | 56.1 | 41.69 | 21.71 | 15.79 | 24.29 | |||||
EBIT, 5 Yr. CAGR % | 56.14 | 41.7 | 21.77 | 15.84 | 24.33 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 56.21 | 41.62 | 22.19 | 15.72 | 24.42 | |||||
Net Income, 5 Yr. CAGR % | 56.21 | 41.62 | 22.19 | 15.72 | 24.42 | |||||
Normalized Net Income, 5 Yr. CAGR % | 56.17 | 41.6 | 22.18 | 15.7 | 24.42 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.94 | 0.68 | -15.98 | -35.42 | -38.39 | |||||
Accounts Receivable, 5 Yr. CAGR % | 105.42 | 181.68 | -26.22 | -21.88 | -41.95 | |||||
Inventory, 5 Yr. CAGR % | - | - | 122.9 | 81.49 | 43.05 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 72.83 | 69.29 | 63.41 | 46.09 | 6.53 | |||||
Total Assets, 5 Yr. CAGR % | 35.39 | 68.5 | 58.58 | 35.1 | -7.62 | |||||
Tangible Book Value, 5 Yr. CAGR % | 28.13 | 69.9 | 74.08 | 37.14 | -9.84 | |||||
Common Equity, 5 Yr. CAGR % | 28.08 | 69.64 | 73.79 | 37.21 | -9.73 | |||||
Cash From Operations, 5 Yr. CAGR % | 57.35 | 46.23 | 18.85 | 8.7 | -0.96 | |||||
Capital Expenditures, 5 Yr. CAGR % | 54.65 | 63.71 | 41.34 | -0.2 | -38.58 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 72.66 | 40.5 | 25.09 | 9.82 | 1.75 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 73.01 | 40.48 | 24.71 | 9.56 | 1.06 |
- Stock Market
- Stocks
- CI Stock
- CI BTU Stock
- Financials Cell Impact AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















